Integra LifeSciences Holdings Corp. engages in the provision of regenerative tissue technologies and neurological solutions dedicated to limiting uncertainty for clinicians. The company is headquartered in Princeton, New Jersey and currently employs 4,427 full-time employees. The company manufactures and sells medical technologies and products in two segments: Codman Specialty Surgical (CSS) and Tissue Technologies (TT). CSS consists of technologies and instrumentations used for specialties, such as neurosurgery, neurocritical care, and otolaryngology. CSS neurosurgical business includes a portfolio of brands, which are used for the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus and other neurological conditions. The company provides instruments that are used in precision, specialty and general surgical procedures. TT includes Wound Reconstruction and Care business, which sells offerings, such as skin and wound repair, plastics and surgical reconstruction products and nerve and tendon repair products. Its products include CUSA Platform, Codman Neurosurgical Accessories, DuraGen Dural Graft Matrix, DuraSeal Dural Sealant System and others.
How did IART's recent EPS compare to expectations?
The most recent EPS for Integra Lifesciences Holdings Corp is $0.54, beating expectations of $0.41.
How did Integra Lifesciences Holdings Corp IART's revenue perform in the last quarter?
Integra Lifesciences Holdings Corp revenue for the last quarter is $0.54
What is the revenue estimate for Integra Lifesciences Holdings Corp?
According to 11 of Wall street analyst, the revenue estimate of Integra Lifesciences Holdings Corp range from $443.24M to $402.54M
What's the earning quality score for Integra Lifesciences Holdings Corp?
Integra Lifesciences Holdings Corp has a earning quality score of B+/52.391396. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.
When does Integra Lifesciences Holdings Corp report earnings?
Integra Lifesciences Holdings Corp next earnings report is expected in 2026-08-03
What are Integra Lifesciences Holdings Corp's expected earnings?
Integra Lifesciences Holdings Corp expected earnings is $389.5M, according to wall-street analysts.
Did Integra Lifesciences Holdings Corp beat earnings expectations?
Integra Lifesciences Holdings Corp recent earnings of $391.91M beat expectations.